Navigation Links
Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results; Nexavar Global Net Sales Top $229 Million, 27% Increase Over Third Quarter 2008
Date:11/3/2009

, regulatory filings and actions and Onyx's anticipated acquisition of Proteolix, Inc. and its lead product candidate, carfilzomib. These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated, including, but not limited to, risks and uncertainties related to: Nexavar being our only approved product; competition; failures or delays in our clinical trials; dependence on our collaborative relationship with Bayer; market acceptance and the rate of adoption of our products; pharmaceutical pricing and reimbursement pressures; serious adverse side effects, if they are associated with Nexavar; government regulation; possible failure to realize the anticipated benefits of business acquisitions or strategic investments; protection of our intellectual property; the indebtedness incurred through the sale of our 4.0% convertible senior notes due 2016; product liability risks; and the consummation and anticipated benefits of the proposed acquisition of Proteolix. Reference should be made to Onyx's Annual Report on Form 10-K for the year ended December 31, 2008, filed with the Securities and Exchange Commission, under the heading "Risk Factors" for a more detailed description of these and other risks, as well as the company's subsequent quarterly reports on Form 10Q. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release. Onyx undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.

                           (See attached tables.)


                        ONYX PHARMACEUTICALS, INC.
                    CONDENSED STATEMENTS OF OPERATIONS
                 (In thousands, except per share amounts)
                                (unaudited)

                    
'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Cumberland Pharmaceuticals to Present at Lazard Healthcare Conference in New York on November 17, 2009
2. Vanda Pharmaceuticals Reports Third Quarter 2009 Results
3. Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity
4. VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference
5. Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009
6. Amira Pharmaceuticals to Present at the BIO Investor Forum in San Francisco
7. Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation
8. DUSA Pharmaceuticals Named to Deloittes 2009 Technology Fast 500 List of Fastest Growing Companies in North America
9. Peregrine Pharmaceuticals Announces Implementation of 1:5 Reverse Stock Split to Take Effect October 19, 2009
10. Proteolix, Inc. to be Acquired By Onyx Pharmaceuticals
11. Amira Pharmaceuticals to Present at Montgomery Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2015)... 02, 2015 Vancouver fencing company, QS Fencing, ... valuable advice to prospective clients related to their questions on ... install railings around their decks and patios. While that seems ... pop up once the person rolls up their sleeve to ... a railing in finding a gate that matches it. , ...
(Date:5/2/2015)... 2015 “ Peachtree Audio ” was ... Report, which features the latest and coolest technology products ... special reporter for NewsWatch, conducted the review and shared ... , Music is an important part of people’s ... and given the royal treatment. Peachtree Audio does just ...
(Date:5/2/2015)... 2015 With the success that Veatch Dental ... to welcome Neida Miranda and Alex Shields to the team. ... over 41 years of combined experience working with dentists to ... dental field for 8 years. She was certified as ... Customer service, positive attitude and showing the importance of oral ...
(Date:5/1/2015)... ME (PRWEB) May 01, 2015 Royal ... in Freeport, Maine, reports on a new study that ... stiffness, joint swelling and improved physical function as well ... with severe osteoarthritis of the knee. , The report ... Natural Insights for Well Being® ,” which Royal River ...
(Date:5/1/2015)... Ernst & Young (EY) has announced ... & CSO, and Burak Sezen, Co-Founder & CTO of ... Entrepreneur Of The Year® 2015 Awards in the Ohio ... a global leader in assurance, tax, transaction and advisory ... the top audit companies in the world. The awards ...
Breaking Medicine News(10 mins):Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:Affordable High-End Audio Equipment was Featured on NewsWatch Television 2Health News:Veatch Dental Consulting Services Welcomes New Team Members 2Health News:New Study Finds Nutrients Ease Arthritis Pain, Retailer Reports 2Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2
... is a strong predictor of coronary artery disease and mortality, ... that patients are nearly 60 percent at risk of having ... levels of abdominal aortic calcium, commonly known as plaque. High ... of dying, researchers say. Conversely, researchers found that ...
... the place of a good clinical exam, study finds , ... but 70 percent of able-bodied professional and collegiate hockey players ... , "This study was done to see if abnormal MRI ... Matthew Silvis, an assistant professor in the department of family ...
... exercise and proper nutrition, expert says , SUNDAY, March ... a large U.S. government-sponsored trial find that neither aggressive ... risk of heart events in people with type 2 ... a lot of people -- that this intensive blood ...
... ... benefits of acupuncture, hypnosis and neuroprogramming without the expense and inconvenience of sitting in doctors ... , ... March 14, 2010 -- AcuAids announces acupuncture at home to stop smoking, lose weight and ...
... Skin ailment boosts odds for heart attack, stroke, and ... 13 (HealthDay News) -- The common skin ailment psoriasis ... other cardiovascular woes, probably through a shared inflammatory response, ... evidence for psoriasis as a risk factor for cardiovascular ...
... attack, even death, study suggests , SATURDAY, March 13 (HealthDay ... for the heart, then turbo-charged workouts like training for marathons ... according to new research by Greek doctors who found that ... that some types of high-intensity exercise may actually be bad ...
Cached Medicine News:Health News:Plaque on CT scan is strong predictor of heart disease, worse long-term outcomes 2Health News:Scans May Be Misleading for Hockey Players 2Health News:Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 Diabetics 2Health News:Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 Diabetics 3Health News:AcuAids Announces Acupuncture at Home to Stop Smoking, Lose Weight and More 2Health News:AcuAids Announces Acupuncture at Home to Stop Smoking, Lose Weight and More 3Health News:Psoriasis Tied to Raised Heart Risk 2Health News:Marathoners Face Greater Risk of Artery Stiffness 2
(Date:4/30/2015)... Abaxis, Inc. (NasdaqGS: ABAX ), a ... reported financial results for the fourth quarter and fiscal ... and fiscal 2015 overview: , Revenues from continuing ... 33% over last year,s comparable quarter, and $202.6 million ... EPS of $0.50 for the fourth quarter, up 194% ...
(Date:4/30/2015)... 2015  IRIDEX Corporation (NASDAQ: IRIX ) today ... financial results after the market closes on Thursday, ... the Company will host a conference call with the ... Thursday, May 7, 2015 to discuss ... Interested parties may access the live conference ...
(Date:4/30/2015)... JOLLA, Calif. , April 30, 2015   ... biopharmaceutical company leading the discovery and development of innovative ... financial results and highlights for the quarter ended March ... U.S. financial markets close. Regulus will ... 7, 2015, at 5:00 pm Eastern Daylight Time to ...
Breaking Medicine Technology:Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 2Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 3Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 4Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 5Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 6Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 7Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 8Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 9Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 10Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 11Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 12Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 13Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 14Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 15Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 16Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 17Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 18Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 19Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 20Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 21Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 22Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 23Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend 24IRIDEX Announces First Quarter 2015 Conference Call and Release Date 2Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 3
... June 16 The first in a planned series ... for millions of Indian cancer patients has been officially opened in ... and Fortis Healthcare, is equipped with advanced radiotherapy equipment and software ... , , ...
... Phytomedics Inc., a clinical stage biopharmaceutical company developing a novel portfolio of ... Dr. Laurie Smaldone , MD, President and Chief Executive Officer, will ... June 17th, 2010 , held at New York ,s Hotel ... , , ...
Cached Medicine Technology:Varian Medical Systems Equips International Oncology's First Comprehensive Cancer Center in India 2Varian Medical Systems Equips International Oncology's First Comprehensive Cancer Center in India 3Phytomedics Inc. to Present at 2010 New York Venture Summit 2
... incubators is available, ensuring the customers to ... specific requirements. miniTHERM incubators have a capacity ... space saving. Their size corresponds approximately to ... to stack up to three units on ...
... the leading name in high ... for more than 15 years. ... brought leading edge technology, such ... sensors,microprocessor control, directed airflow, and ...
... The Dual Media Set, different from commonly ... (LB) or other specially prepared medium, contains ... BROTH (OB). For cell expansion, E. coli ... production of the recombinant protein is almost ...
Listeria Enrichment Broth...
Medicine Products: